Alexion Announces Plans To Initiate Phase 3 Study Of Ultomiris In Hospitalized Patients With Severe Covid-19 Read more
Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients Read more
FDA and EMA accept applications for Roche’s OCREVUS (ocrelizumab) shorter 2-hour infusion time Read more
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients Read more
COVID-19 Update: Highly Potent Active Pharmaceutical Ingredients 2020 now Remote Access only Read more
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit Read more